R2 Technology has filed a patent infringement lawsuit against Intelligent Systems Software, which makes software for computer-aided detection. ISS has denied the alleged infringement. R2's formal complaint, filed June 3 in the U.S. District Court for the
R2 Technology has filed a patent infringement lawsuit against Intelligent Systems Software, which makes software for computer-aided detection. ISS has denied the alleged infringement. R2's formal complaint, filed June 3 in the U.S. District Court for the District of Delaware, charges ISSI with infringing three patents that address the scanning, processing, and display of images. R2 owns or has rights to more than 85 U.S. patents and patent applications, which company executives say they will vigorously protect against any form of infringement.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.